JP2025032102A5 - - Google Patents
Info
- Publication number
- JP2025032102A5 JP2025032102A5 JP2024195562A JP2024195562A JP2025032102A5 JP 2025032102 A5 JP2025032102 A5 JP 2025032102A5 JP 2024195562 A JP2024195562 A JP 2024195562A JP 2024195562 A JP2024195562 A JP 2024195562A JP 2025032102 A5 JP2025032102 A5 JP 2025032102A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- amino acid
- acid sequence
- cgrp antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962789828P | 2019-01-08 | 2019-01-08 | |
| US62/789,828 | 2019-01-08 | ||
| US201962840967P | 2019-04-30 | 2019-04-30 | |
| US62/840,967 | 2019-04-30 | ||
| US201962841585P | 2019-05-01 | 2019-05-01 | |
| US62/841,585 | 2019-05-01 | ||
| US201962872983P | 2019-07-11 | 2019-07-11 | |
| US62/872,983 | 2019-07-11 | ||
| PCT/US2020/012790 WO2020146535A1 (en) | 2019-01-08 | 2020-01-08 | Treatment of medication overuse headache using anti-cgrp or anti-cgrp-r antibodies |
| JP2021539682A JP2022516957A (ja) | 2019-01-08 | 2020-01-08 | 抗ｃｇｒｐ又は抗ｃｇｒｐ－ｒ抗体を用いた薬物乱用頭痛の治療 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021539682A Division JP2022516957A (ja) | 2019-01-08 | 2020-01-08 | 抗ｃｇｒｐ又は抗ｃｇｒｐ－ｒ抗体を用いた薬物乱用頭痛の治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025032102A JP2025032102A (ja) | 2025-03-11 |
| JP2025032102A5 true JP2025032102A5 (https=) | 2025-08-05 |
Family
ID=71404208
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021539682A Withdrawn JP2022516957A (ja) | 2019-01-08 | 2020-01-08 | 抗ｃｇｒｐ又は抗ｃｇｒｐ－ｒ抗体を用いた薬物乱用頭痛の治療 |
| JP2024195562A Pending JP2025032102A (ja) | 2019-01-08 | 2024-11-08 | 抗ｃｇｒｐ又は抗ｃｇｒｐ－ｒ抗体を用いた薬物乱用頭痛の治療 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021539682A Withdrawn JP2022516957A (ja) | 2019-01-08 | 2020-01-08 | 抗ｃｇｒｐ又は抗ｃｇｒｐ－ｒ抗体を用いた薬物乱用頭痛の治療 |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US20200216525A1 (https=) |
| EP (1) | EP3908607A4 (https=) |
| JP (2) | JP2022516957A (https=) |
| KR (1) | KR20210114002A (https=) |
| CN (2) | CN119303074A (https=) |
| AU (1) | AU2020207299A1 (https=) |
| BR (1) | BR112020018044A2 (https=) |
| CA (1) | CA3123292A1 (https=) |
| CL (1) | CL2021001813A1 (https=) |
| CO (1) | CO2021008665A2 (https=) |
| DO (1) | DOP2021000145A (https=) |
| EC (1) | ECSP21052193A (https=) |
| GE (2) | GEAP202515689A (https=) |
| IL (1) | IL284677A (https=) |
| JO (1) | JOP20210166A1 (https=) |
| MA (1) | MA54709A (https=) |
| MX (1) | MX2021008268A (https=) |
| NI (1) | NI202100063A (https=) |
| PE (1) | PE20211708A1 (https=) |
| PH (1) | PH12021551494A1 (https=) |
| SG (1) | SG11202106878XA (https=) |
| TW (1) | TW202030205A (https=) |
| UA (1) | UA129265C2 (https=) |
| WO (1) | WO2020146535A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107827982B (zh) | 2011-05-20 | 2021-07-06 | H.伦德贝克公司 | 抗cgrp抗体和抗体片段用于在有需要的受试者中预防或抑制畏光或厌光的用途 |
| PE20141787A1 (es) | 2011-05-20 | 2014-12-07 | Alderbio Holdings Llc | Composiciones anti-cgrp y uso de las mismas |
| TWI705825B (zh) | 2011-05-20 | 2020-10-01 | 美商艾爾德生物控股有限責任公司 | 抗降血鈣素基因相關胜肽（ａｎｔｉ－ｃｇｒｐ）或抗降血鈣素基因相關胜肽受器（ａｎｔｉ－ｃｇｒｐ－ｒ）抗體或抗體片段治療或預防慢性及急性型腹瀉之用途 |
| US20170114122A1 (en) | 2015-10-23 | 2017-04-27 | Alderbio Holdings Llc | Regulation of glucose metabolism using anti-cgrp antibodies |
| WO2020146527A1 (en) | 2019-01-08 | 2020-07-16 | Alder Biopharmaceuticals, Inc. | Acute treatment and rapid treatment of headache using anti-cgrp antibodies |
| CA3077973A1 (en) | 2020-04-06 | 2021-10-06 | H. Lundbeck A/S | Treatment of most bothersome symptom (mbs) associated with migraine using anti-cgrp antibodies |
| IL310885A (en) * | 2021-08-27 | 2024-04-01 | H Lundbeck As | Treatment of cluster headache using anti-CGRP antibodies |
| EP4570913A1 (en) * | 2022-08-11 | 2025-06-18 | Shanghai Junshi Biosciences Co., Ltd. | Anti-cgrp antibody and use |
| CN118476508A (zh) * | 2024-06-27 | 2024-08-13 | 中国人民解放军总医院第一医学中心 | 一种基于疾病发生特点的药物过度使用性头痛动物模型的构建方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070065463A1 (en) * | 2003-06-20 | 2007-03-22 | Ronald Aung-Din | Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions |
| CN107827982B (zh) * | 2011-05-20 | 2021-07-06 | H.伦德贝克公司 | 抗cgrp抗体和抗体片段用于在有需要的受试者中预防或抑制畏光或厌光的用途 |
| PE20141787A1 (es) * | 2011-05-20 | 2014-12-07 | Alderbio Holdings Llc | Composiciones anti-cgrp y uso de las mismas |
| CN103585449B (zh) * | 2013-10-23 | 2016-06-22 | 高丽丽 | 用于治疗偏头痛的中药组合物 |
| US10899834B2 (en) * | 2015-04-16 | 2021-01-26 | H. Lundbeck A/S | Anti-PACAP antibodies |
| EP3448427A1 (en) * | 2016-04-29 | 2019-03-06 | CureVac AG | Rna encoding an antibody |
| CN109952314A (zh) * | 2016-09-23 | 2019-06-28 | 泰瓦制药国际有限公司 | 治疗难治性偏头痛 |
| WO2020146527A1 (en) * | 2019-01-08 | 2020-07-16 | Alder Biopharmaceuticals, Inc. | Acute treatment and rapid treatment of headache using anti-cgrp antibodies |
-
2020
- 2020-01-08 WO PCT/US2020/012790 patent/WO2020146535A1/en not_active Ceased
- 2020-01-08 SG SG11202106878XA patent/SG11202106878XA/en unknown
- 2020-01-08 US US16/736,937 patent/US20200216525A1/en not_active Abandoned
- 2020-01-08 TW TW109100630A patent/TW202030205A/zh unknown
- 2020-01-08 MA MA054709A patent/MA54709A/fr unknown
- 2020-01-08 AU AU2020207299A patent/AU2020207299A1/en active Pending
- 2020-01-08 GE GEAP202515689A patent/GEAP202515689A/en unknown
- 2020-01-08 BR BR112020018044-0A patent/BR112020018044A2/pt unknown
- 2020-01-08 MX MX2021008268A patent/MX2021008268A/es unknown
- 2020-01-08 UA UAA202104194A patent/UA129265C2/uk unknown
- 2020-01-08 EP EP20738512.1A patent/EP3908607A4/en active Pending
- 2020-01-08 PH PH1/2021/551494A patent/PH12021551494A1/en unknown
- 2020-01-08 CA CA3123292A patent/CA3123292A1/en active Pending
- 2020-01-08 GE GEAP202015689A patent/GEP20257804B/en unknown
- 2020-01-08 PE PE2021001141A patent/PE20211708A1/es unknown
- 2020-01-08 CN CN202411285298.5A patent/CN119303074A/zh active Pending
- 2020-01-08 JO JOP/2021/0166A patent/JOP20210166A1/ar unknown
- 2020-01-08 CN CN202080007409.XA patent/CN113272324A/zh active Pending
- 2020-01-08 KR KR1020217023581A patent/KR20210114002A/ko active Pending
- 2020-01-08 JP JP2021539682A patent/JP2022516957A/ja not_active Withdrawn
-
2021
- 2021-06-30 CO CONC2021/0008665A patent/CO2021008665A2/es unknown
- 2021-07-07 CL CL2021001813A patent/CL2021001813A1/es unknown
- 2021-07-07 IL IL284677A patent/IL284677A/en unknown
- 2021-07-07 DO DO2021000145A patent/DOP2021000145A/es unknown
- 2021-07-07 NI NI202100063A patent/NI202100063A/es unknown
- 2021-07-14 EC ECSENADI202152193A patent/ECSP21052193A/es unknown
-
2023
- 2023-11-16 US US18/511,241 patent/US20240343784A1/en active Pending
-
2024
- 2024-11-08 JP JP2024195562A patent/JP2025032102A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025032102A5 (https=) | ||
| JP2024167313A5 (https=) | ||
| JP2022061992A5 (https=) | ||
| JP2025111463A5 (https=) | ||
| JP2022105138A5 (https=) | ||
| JP2024045121A5 (https=) | ||
| JP2018535650A5 (https=) | ||
| FI3484915T3 (fi) | Uusia zikavirusepitooppeihin spesifisesti sitoutuvia vasta-aineita ja niiden käyttöjä | |
| IL276164B1 (en) | Anti-tmprss2 antibodies and antigen-binding fragments | |
| JP2023542289A5 (https=) | ||
| JP2023071956A5 (https=) | ||
| JP2023081303A5 (https=) | ||
| JP2023541858A5 (https=) | ||
| JP2022540083A5 (https=) | ||
| JP2023541860A5 (https=) | ||
| JP2020509031A5 (https=) | ||
| JP2022512234A5 (https=) | ||
| JP2024520666A5 (https=) | ||
| JP2021501579A5 (https=) | ||
| JP2019521647A5 (https=) | ||
| JP2023542291A5 (https=) | ||
| JP2025128343A5 (https=) | ||
| JP2021531732A5 (https=) | ||
| JP2025038088A5 (https=) | ||
| JP2026004299A5 (https=) |